相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。miR-377-3p drives malignancy characteristics via upregulating GSK-3 expression and activating NF-B pathway in hCRC cells
Wei-Ying Liu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells
Parthasarathy Chandrakesan et al.
MOLECULAR CANCER (2017)
Colorectal cancer statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients
T. Powrozek et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2016)
Tetramethylpyrazine induces SH-SY5Y cell differentiation toward the neuronal phenotype through activation of the PI3K/Akt/Sp1/TopoIIβ pathway
Yong-xin Yan et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2015)
miR-212/132 downregulates SMAD2 expression to suppress the G1/S phase transition of the cell cycle and the epithelial to mesenchymal transition in cervical cancer cells
Jian-Li Zhao et al.
IUBMB LIFE (2015)
Epithelial-mesenchymal transition in colorectal cancer metastasis: A system review
Hui Cao et al.
PATHOLOGY RESEARCH AND PRACTICE (2015)
Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism
Sripathi M. Sureban et al.
ONCOTARGET (2015)
PI3K/AKT signaling modulates transcriptional expression of EWS/FLI1 through specificity protein 1
Chiara Giorgi et al.
ONCOTARGET (2015)
DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma
Nathaniel Weygant et al.
ONCOTARGET (2015)
Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical Implications
Malaney R. O'Connell et al.
SCIENTIFIC REPORTS (2015)
The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers
Hege Marie Vedeld et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Loss of BRMS1 Promotes a Mesenchymal Phenotype through NF-kappa B-Dependent Regulation of Twist1
Yuan Liu et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
MiR-124 represses vasculogenic mimicry and cell motility by targeting amotL1 in cervical cancer cells
Hai-Ying Wan et al.
CANCER LETTERS (2014)
The recently suggested intestinal cancer stem cell marker DCLK1 is an epigenetic biomarker for colorectal cancer
Hege Marie Vedeld et al.
EPIGENETICS (2014)
DCLK1 Marks a Morphologically Distinct Subpopulation of Cells With Stem Cell Properties in Preinvasive Pancreatic Cancer
Jennifer M. Bailey et al.
GASTROENTEROLOGY (2014)
Dclk1 distinguishes between tumor and normal stem cells in the intestine
Yuki Nakanishi et al.
NATURE GENETICS (2013)
CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer
T. J. Liu et al.
ONCOGENE (2013)
DCLK1 Regulates Pluripotency and Angiogenic Factors via microRNA-Dependent Mechanisms in Pancreatic Cancer
Sripathi M. Sureban et al.
PLOS ONE (2013)
Sp1 is involved in regulation of cystathionine γ-lyase gene expression and biological function by PI3K/Akt pathway in human hepatocellular carcinoma cell lines
Peng Yin et al.
CELLULAR SIGNALLING (2012)
Novel target genes and a valid biomarker panel identified for cholangiocarcinoma
Kim Andresen et al.
EPIGENETICS (2012)
DCAMKL-1 Regulates Epithelial-Mesenchymal Transition in Human Pancreatic Cells through a miR-200a-Dependent Mechanism
Sripathi M. Sureban et al.
CANCER RESEARCH (2011)
Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism
Sripathi M. Sureban et al.
JOURNAL OF NANOBIOTECHNOLOGY (2011)
EMT, the cytoskeleton, and cancer cell invasion
Mahmut Yilmaz et al.
CANCER AND METASTASIS REVIEWS (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
The morphological and molecular features of the epithelial-to-mesenchymal transition
Gema Moreno-Bueno et al.
NATURE PROTOCOLS (2009)
NF-κB and epithelial to mesenchymal transition of cancer
Chengyin Min et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Snail, ZEB and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
Hector Peinado et al.
NATURE REVIEWS CANCER (2007)
NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells:: potential involvement of ZEB-1 and ZEB-2
H. L. Chua et al.
ONCOGENE (2007)
Epidemiology and management of liver metastases from colorectal cancer
Sylvain Manfredi et al.
ANNALS OF SURGERY (2006)
Differential regulation of TCR-mediated gene transcription by Vav family members
S Zakaria et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Stat3 enhances vimentin gene expression by binding to the antisilencer element and interacting with the repressor protein, ZBP-89
YZ Wu et al.
ONCOGENE (2004)
Role of the IκB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells
M Arsura et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
